Implications of lowering threshold of plasma troponin concentration in diagnosis of myocardial infarction: Cohort study

BMJ (Online)

Volumn 344, Issue 7852, 2012, Pages

  Mills, Nicholas L ^a   Lee, Kuan Ken ^a   McAllister, David A ^b   Churchhouse, Antonia M D ^a   MacLeod, Margaret ^c   Stoddart, Mary ^c   Walker, Simon ^c   Denvir, Martin A ^a   Fox, Keith A A ^a   Newby, David E ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

TROPONIN I; TROPONIN;

ACUTE CORONARY SYNDROME; ARTICLE; COHORT ANALYSIS; DIAGNOSTIC VALUE; HEART INFARCTION; HOSPITAL READMISSION; HUMAN; MAJOR CLINICAL STUDY; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; RISK ASSESSMENT; AGED; ANALYTICAL EQUIPMENT; BLOOD; FEMALE; MALE; MIDDLE AGED; OUTCOME ASSESSMENT; RECURRENT DISEASE; REFERENCE VALUE; SENSITIVITY AND SPECIFICITY; STANDARD; UNITED KINGDOM;

ACUTE CORONARY SYNDROME; AGED; COHORT STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; OUTCOME ASSESSMENT (HEALTH CARE); PROGNOSIS; REAGENT KITS, DIAGNOSTIC; RECURRENCE; REFERENCE VALUES; RISK ASSESSMENT; SCOTLAND; SENSITIVITY AND SPECIFICITY; TROPONIN;

EID: 84859700953     PISSN: None     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.e1533     Document Type: Article

References (27)

1. Thygesen K, Alpert JS, White HD, Jaffe AS, Apple FS, Galvani M, et al. Universal definition of myocardial infarction. Circulation 2007;116:2634-53. (Pubitemid 350182388)
2. Bauer A, Gawaz M. Sensitive cardiac troponin assays. N Engl J Med 2009;361:2575-7.
3. Morrow DA, Cannon CP, Jesse RL, Newby LK, Ravkilde J, Storrow AB, et al. National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: clinical characteristics and utilization of biochemical markers in acute coronary syndromes. Clin Chem 2007;53:552-74. (Pubitemid 46580223)
4. Mills NL, Churchhouse AM, Lee KK, Anand A, Gamble D, Shah AS, et al. Implementation of a sensitive troponin I assay and risk of recurrent myocardial infarction and death in patients with suspected acute coronary syndrome. JAMA 2011;305:1210-6.
5. Jaffe AS, Apple FS, Morrow DA, Lindahl B, Katus HA. Being rational about (im)precision: a statement from the Biochemistry Subcommittee of the Joint European Society of Cardiology/American College of Cardiology Foundation/American Heart Association/World Heart Federation Task Force for the definition of myocardial infarction. Clin Chem 2010;56:941-3.
6. Kupchak P, Wu AH, Ghani F, Newby LK, Ohman EM, Christenson RH. Influence of imprecision on ROC curve analysis for cardiac markers. Clin Chem 2006;52:752-3.
7. Antman EM, Tanasijevic MJ, Thompson B, Schactman M, McCabe CH, Cannon CP, et al. Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes. N Engl J Med 1996:335;1342-9. (Pubitemid 26360452)
8. Lindahl B, Venge P, Wallentin L, the FRISC Study Group. Relation between troponin T and the risk of subsequent cardiac events in unstable coronary artery disease. Circulation 1996:93;1651-7.
9. Lindahl B, Toss H, Siegbahn A, Venge P, Wallentin L. Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease. N Engl J Med 2000:343;1139-47.
10. Morrow DA, Cannon CP, Rifai N, Frey MJ, Vicari R, Lakkis N, et al. Ability of minor elevations of troponins I and T to predict benefit from an early invasive strategy in patients with unstable angina and non-ST elevation myocardial infarction. JAMA 2001:286;2405-12. (Pubitemid 33098158)
11. Morrow DA. Clinical application of sensitive troponin assays. N Engl J Med. 2009;361:913-5.
12. Bonaca M, Scirica B, Sabatine M, Dalby A, Spinar J, Murphy SA, et al. Prospective evaluation of the prognostic implications of improved assay performance with a sensitive assay for cardiac troponin I. J Am Coll Cardiol 2010;55:2118-24.
13. Lindahl B, Venge P, James S. The new high-sensitivity cardiac troponin T assay improves risk assessment in acute coronary syndromes. Am Heart J 2010;160:224-9.
14. Meune C, Drexler B, Haaf P, Reichlin T, Reiter M, Meissner J, et al. The GRACE score's performance in predicting in-hospital and 1-year outcome in the era of high-sensitivity cardiac troponin assays and B-type natriuretic peptide. Heart 2011;97:1479-83.
15. Body R, Carley S, McDowell G, Jaffe AS, France M, Cruickshank K, et al. Rapid exclusion of acute myocardial infarction in patients with undetectable troponin using a high-sensitivity assay. J Am Coll Cardiol 2011;58:1332-9
16. Collinson P, Goodacre S, Gaze D, Gray A. Very early diagnosis of chest pain by point-of-care testing: comparison of the diagnostic efficiency of a panel of cardiac biomarkers compared with troponin measurement alone in the RATPAC trial. Heart 2012:98;312-8.
17. NHS National Services Scotland: Information Services Division (ISD). Hospital activity in coronary heart disease. National Statistics Publication for Scotland, 2011;xx:1-20.
18. Myocardial Ischaemia National Audit Project (MINAP). How the NHS cares for patients with heart attack. 10th public report. National Institute for Cardiovascular Research, 2011;xx:1-84.
19. Eggers KM, Jaffe AS, Lind L, Venge P, Lindahl B. Value of cardiac troponin I cutoff concentrations below the 99th percentile for clinical decision-making. Clin Chem 2009;55:85-92.
20. Apple FS, Simpson PA, Murakami MM. Defining the serum 99th percentile in a normal reference population measured by a high-sensitivity cardiac troponin I assay. Clin Biochem 2010;43:1034-6.
21. Koerbin G, Tate JR, Hickman PE. Analytical characteristics of the Roche highly sensitive troponin T assay and its application to a cardio-healthy population. Ann Clin Biochem 2010;47:524-8.
22. Mingels A, Jacobs L, Michielsen E, Swaanenburg J, Wodzig W, van Dieijen-Visser M. Reference population and marathon runner sera assessed by highly sensitive cardiac troponin T and commercial cardiac troponin T and I assays. Clin Chem 2009;55:101-8.
23. Omland T, de Lemos JA, Sabatine MS, Christophi CA, Rice MM, Jablonski KA, et al. A sensitive cardiac troponin T assay in stable coronary artery disease. N Engl J Med 2009;361:2538-47.
24. Venge P, Johnston N, Lindahl B, James S. Normal plasma levels of cardiac troponin I measured by the high-sensitivity cardiac troponin I access prototype assay and the impact on the diagnosis of myocardial ischemia. J Am Coll Cardiol 2009;54:1165-72.
25. Sabatine MS, Morrow DA, de Lemos JA, Jarolim P, Braunwald E. Detection of acute changes in circulating troponin in the setting of transient stress test-induced myocardial ischaemia using an ultrasensitive assay: results from TIMI 35. Eur Heart J 2009;30:162-9.
26. Apple FS. A new season for cardiac troponin assays: it's time to keep a scorecard. Clin Chem 2009;55:1303-6.
27. Eggers KM, Lind L, Ahlstrom H, Bjerner T, Ebeling Barbier C, Larsson A, et al. Prevalence and pathophysiological mechanisms of elevated cardiac troponin I levels in a population-based sample of elderly subjects. Eur Heart J 2008;29:2252-8.